This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.
BigData in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of bigdata in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. With machine learning and bigdata analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns.
Precision Medicine Marketing: Drugs like Keytruda , designed for specific genetic profiles, have revolutionized treatment approaches. BigData: Data-driven insights guide targeted advertising and refine messaging for different audience segments. Tailored video content or interactive apps can help meet these expectations.
The name Zeneca was invented by a branding consultancy who had been instructed to find a name which was memorable, had no associations with other companies, nor was offensive in any language”. The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin.
The rise of bigdata analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.
This data-driven approach is helping companies optimize their marketing spend while maximizing impact and reach. Personalized Medicine and Targeted Campaigns Personalized medicine is revolutionizing the pharmaceutical industry by tailoring treatments to individual genetic profiles and health conditions.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content